Skip to main content
main-content

Zeitschrift

Experimental Hematology & Oncology

Experimental Hematology & Oncology 1/2017

Ausgabe 1/2017

Inhaltsverzeichnis ( 32 Artikel )

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer

Michele Moschetta, Gabriel Mak, Joana Hauser, Catriona Davies, Mario Uccello, Hendrik-Tobias Arkenau

01.12.2017 | Research | Ausgabe 1/2017 Open Access

Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche

Natalia-Del Pilar Vanegas, Jean-Paul Vernot

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Molecular classification of tissue from a transformed non-Hogkin’s lymphoma case with unexpected long-time remission

Julie Støve Bødker, Marianne Tang Severinsen, Tarec Christoffer El-Galaly, Rasmus Froberg Brøndum, Maria Bach Laursen, Steffen Falgreen, Mette Nyegaard, Alexander Schmitz, Lasse Hjort Jakobsen, Anna Amanda Schönherz, Hanne Due, Linn Reinholdt, Martin Bøgsted, Karen Dybkær, Hans Erik Johnsen

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab

Gabriela Andries, Michael Karass, Srikanth Yandrapalli, Katherine Linder, Delong Liu, John Nelson, Rahul Pawar, Savneek Chugh

01.12.2017 | Research | Ausgabe 1/2017 Open Access

A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercises

Stefan S. Schönsteiner, Heidi Bauder Mißbach, Axel Benner, Silja Mack, Thomas Hamel, Michael Orth, Bernhard Landwehrmeyer, Sigurd D. Süßmuth, Carolin Geitner, Regine Mayer-Steinacker, Anneliese Riester, Andrea Prokein, Elfriede Erhardt, Jelena Kunecki, Anna M. Eisenschink, Rainer Rawer, Hartmut Döhner, Elisabeth Kirchner, Richard F. Schlenk

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months

Riccardo Marconcini, Luca Galli, Andrea Antonuzzo, Simona Bursi, Claudia Roncella, Gabriella Fontanini, Elisa Sensi, Alfredo Falcone

01.12.2017 | Review | Ausgabe 1/2017 Open Access

nab-Paclitaxel for the treatment of breast cancer: an update across treatment settings

Adam Brufsky

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Acquired factor VIII deficiency: two case reports and a review of literature

Lan Mo, George C. Bao

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions

Nikki Charlotta Paul Granacher, Zwi N. Berneman, Wilfried Schroyens, Ann L. R. Van de Velde, Anke Verlinden, Alain P. A. Gadisseur

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia

Guoqing Wei, Lijuan Ding, Jiasheng Wang, Yongxian Hu, He Huang

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Metastatic squamous cell carcinoma of colon from esophageal cancer

Natasha Garg, Constance Stoehr, Yan Shi Zhao, Heather Rojas, Chung-Tsen Hsueh

01.12.2017 | Review | Ausgabe 1/2017 Open Access

The development of bispecific antibodies and their applications in tumor immune escape

Xiaolong Zhang, Yuanyuan Yang, Dongmei Fan, Dongsheng Xiong

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Cyclosporine is a potential curative treatment option for advanced thymoma

Yusuke Isshiki, Hiroaki Tanaka, Yoshio Suzuki, Yukihiro Yoshida

01.12.2017 | Research | Ausgabe 1/2017 Open Access

Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL

Virginie Nägele, Andrea Kratzer, Gerhard Zugmaier, Chris Holland, Youssef Hijazi, Max S. Topp, Nicola Gökbuget, Patrick A. Baeuerle, Peter Kufer, Andreas Wolf, Matthias Klinger

01.12.2017 | Letter to the Editor | Ausgabe 1/2017 Open Access

In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockade

Eric Bartee, Zihai Li

01.12.2017 | Research | Ausgabe 1/2017 Open Access

Clinical implications of c-maf expression in plasma cells from patients with multiple myeloma

GuoQing Wei, LiJun Wang, HanJin Yang, XiaoYan Han, GaoFeng Zheng, WeiYan Zheng, Jie Sun, JiMin Shi, WenJun Wu, Yi Zhao, DongHua He, Bo Wang, Zhen Cai, JingSong He

01.12.2017 | Review | Ausgabe 1/2017 Open Access

The role of cullin4B in human cancers

Ying Li, Xin Wang

01.12.2017 | Research | Ausgabe 1/2017 Open Access

Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis

Silvia R. Brandalise, Rosemary Assis, Angelo B. A. Laranjeira, José Andrés Yunes, Pedro O. de Campos-Lima

01.12.2017 | Research | Ausgabe 1/2017 Open Access

PTEN is a negative regulator of mitotic checkpoint complex during the cell cycle

Byeong H. Choi, Steve Xie, Wei Dai

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era

Li Zhang, Yu-Tzu Tai, Matthew Zhi Guang Ho, Lugui Qiu, Kenneth C. Anderson

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature

Daniel E. Ezekwudo, Rebecca Chacko, Bolanle Gbadamosi, Syeda Batool, Sussana Gaikazian, Theodore E. Warkentin, Jo-Ann I. Sheppard, Ishmael Jaiyesimi

01.12.2017 | Short report | Ausgabe 1/2017 Open Access

Microfluidic device for primary tumor spheroid isolation

Jiaojiao Zhou, Jimmy Su, Xiaotong Fu, Lei Zheng, Zhizhong Yin

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Pivotal regulators of tissue homeostasis and cancer: macrophages

Yulei Chen, Xiaobo Zhang

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Optimizing peripheral blood stem cells transplantation outcome through amend relapse and graft failure: a review of current literature

Saeed Mohammadi, Amir Hossein Norooznezhad, Ashraf Malek Mohammadi, Hajar Nasiri, Mohsen Nikbakht, Najmaldin Saki, Mohammad Vaezi, Kamran Alimoghaddam, Ardeshir Ghavamzadeh

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Complete biochemical response after pulmonary metastasectomy in prostate adenocarcinoma

Jonathan Rush, Reet Pai, Rahul A. Parikh

01.12.2017 | Research | Ausgabe 1/2017 Open Access

Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients

Rohit Bishnoi, Ravneet Bajwa, Aaron J. Franke, William Paul Skelton IV, Yu Wang, Niraj M. Patel, William Birdsall Slayton, Fei Zou, Nam H. Dang

01.12.2017 | Research | Ausgabe 1/2017 Open Access

Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study

Jennifer Brown, Ruth Plummer, Todd M. Bauer, Stephen Anthony, John Sarantopoulos, Filip De Vos, Mike White, Marco Schupp, Ying Ou, Ulka Vaishampayan

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Incorporation of functional elements enhances the antitumor capacity of CAR T cells

Le Qin, Ruocong Zhao, Peng Li

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Extraordinary clinical benefit to sequential treatment with targeted therapy and immunotherapy of a BRAF V600E and PD-L1 positive metastatic lung adenocarcinoma

Shuyu D. Li, Annia Martial, Alexa B. Schrock, Jane J. Liu

01.12.2017 | Research | Ausgabe 1/2017 Open Access

Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)

Lucia Masarova, C. Cameron Yin, Jorge E. Cortes, Marina Konopleva, Gautam Borthakur, Kate J. Newberry, Hagop M. Kantarjian, Carlos E. Bueso-Ramos, Srdan Verstovsek

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment

Shengnan Yu, Qian Liu, Xinwei Han, Shuang Qin, Weiheng Zhao, Anping Li, Kongming Wu

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis

Mauricio Sarmiento Maldonado, Pablo Ramírez Villanueva, Pablo Bertín Cortes-Monroy, Veronica Jara Arias, Katherine Soto Donoso, Pablo Uribe Gonzalez, Mauricio Ocqueteau Tachini, Jose Antonio Perez-Simón

Aktuelle Ausgaben


 

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise